STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] CRA INTERNATIONAL, INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

CRA International, Inc. (CRAI) executive vice president and general counsel reported multiple open-market sales of company common stock. On 11/20/2025, the reporting person sold 1,317 shares at a weighted average price of $174.1586, 343 shares at $174.8737, 60 shares at $175.4279, and 30 shares at $176.3925, all coded as sales.

After these transactions, the reporting person beneficially owned 15,573 shares of CRA International common stock held directly. The filing notes that all transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 8, 2024, and that the prices shown are weighted averages for trades executed within specified intraday price ranges.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Yellin Jonathan D

(Last) (First) (Middle)
200 CLARENDON STREET

(Street)
BOSTON MA 02116

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CRA INTERNATIONAL, INC. [ CRAI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP AND GENERAL COUNSEL
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 S 1,317 D $174.1586(1) 16,006 D(2)
Common Stock 11/20/2025 S 343 D $174.8737(3) 15,663 D(2)
Common Stock 11/20/2025 S 60 D $175.4279(4) 15,603 D(2)
Common Stock 11/20/2025 S 30 D $176.3925(5) 15,573 D(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $173.59 to $174.56, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
2. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2024.
3. The price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.60 to $175.20, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
4. The price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.22 to $175.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
5. The price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $176.31 to $176.8050, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Delia J. Makhlouta, by power of attorney 11/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the CRAI executive report on this Form 4?

The CRA International (CRAI) executive vice president and general counsel reported several open-market sales of common stock on 11/20/2025, reducing her directly held shares to 15,573.

How many CRAI shares were sold in total by the reporting person?

The reporting person sold 1,317 shares, 343 shares, 60 shares, and 30 shares of CRA International common stock on 11/20/2025, all reported as sales.

At what prices were the CRAI shares sold on 11/20/2025?

The CRAI shares were sold at weighted average prices of $174.1586, $174.8737, $175.4279, and $176.3925, each reflecting multiple trades within stated intraday price ranges.

Does this CRAI Form 4 involve a Rule 10b5-1 trading plan?

Yes. The filing states that the transactions were effected under a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2024.

What is the reporting person’s role at CRA International (CRAI)?

The reporting person is identified as an officer of CRA International, serving as EVP and General Counsel.

How many CRAI shares does the insider own after the reported trades?

Following the reported transactions, the filing shows that the reporting person beneficially owned 15,573 shares of CRA International common stock directly.
Cra Intl Inc

NASDAQ:CRAI

CRAI Rankings

CRAI Latest News

CRAI Latest SEC Filings

CRAI Stock Data

1.17B
6.31M
3.87%
93.61%
3.38%
Consulting Services
Services-legal Services
Link
United States
BOSTON